Potential Benefits of Sonic Augmentation Technology in Music
Launched by UNIVERSITY OF FLORIDA · Jul 3, 2025
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how listening to music enhanced with a special technology called Sonic Augmentation Technology (SAT) might help improve health and well-being. Researchers want to see what immediate effects this enhanced music has on the body and mind, and whether certain personal traits affect these benefits. To do this, participants will listen to a 15-minute music session with this technology and provide saliva samples before and after to measure changes.
If you are between 18 and 89 years old and comfortable reading and understanding English, you may be eligible to take part. Participants will be asked to complete short surveys online before and after the music session and provide small saliva samples to help the researchers study how the body responds. The study is not yet recruiting, but it offers a simple way to explore how music might support health in new and interesting ways.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Between the ages of 18 and 89
- • Proficient in English
- Exclusion Criteria:
- • •Over the age of 89
About University Of Florida
The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Lourdes P. Dale, PhD
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported